BlueCrest Capital Management »

SPDR S&P Biotech shares owned by BlueCrest Capital Management

Quarter-by-quarter ownership of SPDR S&P Biotech (XBI) shares owned by BlueCrest Capital Management from 13F filings

Historical chart of BlueCrest Capital Management investment in SPDR S&P Biotech

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Biotech held by BlueCrest Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Biotech by BlueCrest Capital Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $138M 1.5M 90.06
2018-06-30 $1.8M 19k 95.17
2017-12-31 $4.2M 50k 84.87
2017-09-30 $6.0M 69k 86.57
2017-06-30 $891k 12k 77.16

More positions owned by BlueCrest Capital Management

Spdr Gold Tr Gold Shs (GLD)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr S&p 100 Etf (OEF)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
PG&E Corporation (PCG)
Alphabet Cap Stk Cl A (GOOGL)
Crocs Call Option (CROX)
Spdr Series Trust S&p Oilgas Exp (XOP)
Amazon (AMZN)
Kraneshares Trust Csi Chi Internet (KWEB)
Ishares Tr Iboxx Hi Yd Etf Put Option (HYG)
Meta Platforms Cl A (META)
Ishares Ethereum Tr SHS (ETHA)

View all positions for BlueCrest Capital Management

Top funds holding SPDR S&P Biotech

Goldman Sachs Group
Healthcare Of Ontario Pension Plan Trust Fund
Jpmorgan Chase & Co
Morgan Stanley
Susquehanna International
Citadel Advisors
Jane Street
Bnp Paribas Arbitrage, Snc
Millennium Management
Peak6
UBS Group
Wells Fargo & Company
Barclays
Balyasny Asset Management
Canada Pension Plan Investment Board

View all funds holding SPDR S&P Biotech